Perrigo Company plc Capital Expenditures
Perrigo Company plc (PRGO) reported Capital Expenditures of $28.10 million for the 6-month period ending 2026-06-27, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-05
- Perrigo Company plc payments to acquire property, plant, and equipment for the quarter ending 2026-06-27 was $14.30M, a 25.52% decline year-over-year.
- Perrigo Company plc payments to acquire property, plant, and equipment for the quarter ending 2026-03-28 was $13.80M, a 45.88% decline year-over-year.
- Perrigo Company plc payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $26.80M, a 28.91% decline year-over-year.
- Perrigo Company plc payments to acquire property, plant, and equipment for the quarter ending 2025-09-27 was $21.90M, a 19.19% decline year-over-year.
- Perrigo Company plc payments to acquire property, plant, and equipment for fiscal 2025 was $93.40M, a 21.05% decline from fiscal 2024.
- Perrigo Company plc payments to acquire property, plant, and equipment for fiscal 2024 was $118.30M, a 16.32% increase from fiscal 2023.
- Perrigo Company plc payments to acquire property, plant, and equipment for fiscal 2023 was $101.70M, a 5.50% increase from fiscal 2022.
- Perrigo Company plc payments to acquire property, plant, and equipment for fiscal 2022 was $96.40M, a 36.62% decline from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-27 | $14.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $28.10M 10-Q · filed 2026-08-05 | $54.90M derived: sum of 3 quarters · filed 2026-08-05 | $76.80M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-28 | $13.80M 10-Q · filed 2026-05-06 | $40.60M derived: sum of 2 quarters · filed 2026-05-06 | $62.50M derived: sum of 3 quarters · filed 2026-05-06 | $81.70M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $26.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $48.70M derived: sum of 2 quarters · filed 2026-02-26 | $67.90M derived: sum of 3 quarters · filed 2026-08-05 | $93.40M 10-K · filed 2026-02-26 |
| 2025-09-27 | $21.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $41.10M derived: sum of 2 quarters · filed 2026-08-05 | $66.60M 10-Q · filed 2025-11-05 | $104.30M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-28 | $19.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $44.70M 10-Q · filed 2026-08-05 | $82.40M derived: sum of 3 quarters · filed 2026-08-05 | $109.50M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-29 | $25.50M 10-Q · filed 2026-05-06 | $63.20M derived: sum of 2 quarters · filed 2026-05-06 | $90.30M derived: sum of 3 quarters · filed 2026-05-06 | $118.70M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $37.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $64.80M derived: sum of 2 quarters · filed 2026-02-26 | $93.20M derived: sum of 3 quarters · filed 2026-02-26 | $118.30M 10-K · filed 2026-02-26 |
| 2024-09-28 | $27.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $55.50M derived: sum of 2 quarters · filed 2025-11-05 | $80.60M 10-Q · filed 2025-11-05 | $107.30M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-29 | $28.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $53.50M 10-Q · filed 2025-08-06 | $80.20M derived: sum of 3 quarters · filed 2026-02-26 | $112.00M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-30 | $25.10M 10-Q · filed 2025-05-07 | $51.80M derived: sum of 2 quarters · filed 2026-02-26 | $83.60M derived: sum of 3 quarters · filed 2026-02-26 | $103.60M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $26.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $58.50M derived: sum of 2 quarters · filed 2026-02-26 | $78.50M derived: sum of 3 quarters · filed 2026-02-26 | $101.70M 10-K · filed 2026-02-26 |
| 2023-09-30 | $31.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $51.80M derived: sum of 2 quarters · filed 2024-11-06 | $75.00M 10-Q · filed 2024-11-06 | $101.40M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-07-01 | $20.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $43.20M 10-Q · filed 2024-08-02 | $69.60M derived: sum of 3 quarters · filed 2025-02-28 | $90.90M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-04-01 | $23.20M 10-Q · filed 2024-05-07 | $49.60M derived: sum of 2 quarters · filed 2025-02-28 | $70.90M derived: sum of 3 quarters · filed 2025-02-28 | $99.30M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $26.40M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $47.70M derived: sum of 2 quarters · filed 2025-02-28 | $76.10M derived: sum of 3 quarters · filed 2025-02-28 | $96.40M 10-K · filed 2025-02-28 |
| 2022-10-01 | $21.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $49.70M derived: sum of 2 quarters · filed 2023-11-07 | $70.00M 10-Q · filed 2023-11-07 | $111.70M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-07-02 | $28.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $48.70M 10-Q · filed 2023-08-08 | $90.40M derived: sum of 3 quarters · filed 2024-02-27 | $132.40M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-04-02 | $20.30M 10-Q · filed 2023-05-09 | $62.00M derived: sum of 2 quarters · filed 2024-02-27 | $104.00M derived: sum of 3 quarters · filed 2024-02-27 | $127.00M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $41.70M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $83.70M derived: sum of 2 quarters · filed 2024-02-27 | $106.70M derived: sum of 3 quarters · filed 2024-02-27 | $152.10M 10-K · filed 2024-02-27 |
| 2021-10-02 | $42.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $65.00M derived: sum of 2 quarters · filed 2022-11-08 | $110.40M 10-Q · filed 2022-11-08 | $176.50M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-07-03 | $23.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $68.40M 10-Q · filed 2022-08-09 | $134.50M derived: sum of 3 quarters · filed 2023-02-28 | $178.70M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-04-03 | $45.40M 10-Q · filed 2022-05-11 | $111.50M derived: sum of 2 quarters · filed 2023-02-28 | $155.70M derived: sum of 3 quarters · filed 2023-02-28 | $182.00M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $66.10M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $110.30M derived: sum of 2 quarters · filed 2023-02-28 | $136.60M derived: sum of 3 quarters · filed 2023-02-28 | $170.40M 10-K · filed 2023-02-28 |
| 2020-09-26 | $44.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $70.50M derived: sum of 2 quarters · filed 2021-11-12 | $104.30M 10-Q · filed 2021-11-12 | $151.70M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-27 | $26.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $60.10M 10-Q · filed 2021-08-11 | $107.50M derived: sum of 3 quarters · filed 2022-03-01 | $143.10M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-28 | $33.80M 10-Q · filed 2021-05-12 | $81.20M derived: sum of 2 quarters · filed 2022-03-01 | $116.80M derived: sum of 3 quarters · filed 2022-03-01 | $150.40M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $47.40M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $83.00M derived: sum of 2 quarters · filed 2022-03-01 | $116.60M derived: sum of 3 quarters · filed 2022-03-01 | $137.70M 10-K · filed 2022-03-01 |
| 2019-09-28 | $35.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $69.20M derived: sum of 2 quarters · filed 2020-11-05 | $90.30M 10-Q · filed 2020-11-05 | $136.10M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-29 | $33.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $54.70M 10-Q · filed 2020-08-05 | $100.50M derived: sum of 3 quarters · filed 2021-03-01 | $124.00M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-30 | $21.10M 10-Q · filed 2020-05-05 | $66.90M derived: sum of 2 quarters · filed 2021-03-01 | $90.40M derived: sum of 3 quarters · filed 2021-03-01 | $110.30M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $45.80M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $69.30M derived: sum of 2 quarters · filed 2021-03-01 | $89.20M derived: sum of 3 quarters · filed 2021-03-01 | $102.60M 10-K · filed 2021-03-01 |
| 2018-09-29 | $23.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $43.40M derived: sum of 2 quarters · filed 2019-11-06 | $56.80M 10-Q · filed 2019-11-06 | $90.20M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | $19.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $33.30M 10-Q · filed 2019-08-08 | $66.70M derived: sum of 3 quarters · filed 2020-02-27 | $84.70M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-03-31 | $13.40M 10-Q · filed 2019-05-09 | $46.80M derived: sum of 2 quarters · filed 2020-02-27 | $64.80M derived: sum of 3 quarters · filed 2020-02-27 | $80.00M derived: sum of 4 quarters · filed 2020-02-27 |
| 2017-12-31 | $33.40M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $51.40M derived: sum of 2 quarters · filed 2020-02-27 | $66.60M derived: sum of 3 quarters · filed 2020-02-27 | $88.60M 10-K · filed 2020-02-27 |
| 2017-09-30 | $18.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $33.20M derived: sum of 2 quarters · filed 2018-11-08 | $55.20M 10-Q · filed 2018-11-08 | $76.80M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-07-01 | $15.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $37.20M 10-Q · filed 2018-08-09 | $58.80M derived: sum of 3 quarters · filed 2019-02-27 | $86.30M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-04-01 | $22.00M 10-Q · filed 2018-05-08 | $43.60M derived: sum of 2 quarters · filed 2019-02-27 | $71.10M derived: sum of 3 quarters · filed 2019-02-27 | $93.50M derived: sum of 4 quarters · filed 2019-02-27 |
| 2016-12-31 | $21.60M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $49.10M derived: sum of 2 quarters · filed 2019-02-27 | $71.50M derived: sum of 3 quarters · filed 2019-02-27 | $106.20M 10-K · filed 2019-02-27 |
| 2016-10-01 | $27.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $49.90M derived: sum of 2 quarters · filed 2017-11-09 | $84.60M 10-Q · filed 2017-11-09 | $123.80M derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-07-02 | $22.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | $57.10M 10-Q · filed 2017-08-10 | $96.30M derived: sum of 3 quarters · filed 2018-03-01 | $134.90M derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-04-02 | $34.70M 10-Q · filed 2017-05-30 | $73.90M derived: sum of 2 quarters · filed 2018-03-01 | $112.50M derived: sum of 3 quarters · filed 2018-03-01 | $169.60M derived: sum of 4 quarters · filed 2018-03-01 |
| 2015-12-31 | $39.20M derived: 10-K 6 month − 10-Q 3 month · filed 2018-03-01 | $77.80M 10-K · filed 2018-03-01 | $134.90M derived: sum of 3 quarters · filed 2018-03-01 | $166.80M derived: sum of 4 quarters · filed 2018-03-01 |
| 2015-09-26 | $38.60M 10-Q · filed 2015-11-02 | $95.70M derived: sum of 2 quarters · filed 2017-05-22 | $127.60M 10-Q/A · filed 2017-05-23 | $143.90M derived: sum of 4 quarters · filed 2017-05-22 |
| 2015-06-27 | $57.10M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2017-05-22 | $89.00M 10-Q/A · filed 2017-05-22 | $105.30M derived: sum of 3 quarters · filed 2017-05-22 | $137.00M 10-K · filed 2018-03-01 |
| 2015-03-28 | $31.90M 10-Q/A · filed 2017-05-22 | $48.20M derived: sum of 2 quarters · filed 2017-05-22 | $79.80M 10-Q · filed 2015-04-29 | $131.50M derived: sum of 4 quarters · filed 2017-05-22 |
| 2014-12-27 | $16.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-05 | $48.00M 10-Q · filed 2015-02-05 | $99.60M derived: sum of 3 quarters · filed 2017-05-22 | $141.80M derived: sum of 4 quarters · filed 2017-05-22 |
| 2014-09-27 | $31.70M 10-Q · filed 2015-11-02 | $83.30M derived: sum of 2 quarters · filed 2017-05-22 | $125.50M derived: sum of 3 quarters · filed 2017-05-22 | $162.90M derived: sum of 4 quarters · filed 2017-05-22 |
| 2014-06-28 | $51.60M derived: 10-K 12 month − 10-Q 9 month · filed 2017-05-22 | $93.80M derived: sum of 2 quarters · filed 2017-05-22 | $131.20M derived: sum of 3 quarters · filed 2017-05-22 | $171.60M 10-K · filed 2017-05-22 |
| 2014-03-29 | $42.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-04-29 | $79.60M derived: sum of 2 quarters · filed 2015-04-29 | $120.00M 10-Q · filed 2015-04-29 | $160.60M derived: sum of 4 quarters · filed 2016-02-25 |
| 2013-12-28 | $37.40M derived: 10-Q 6 month − 8-K 3 month · filed 2015-02-05 | $77.80M 10-Q · filed 2015-02-05 | $118.40M derived: sum of 3 quarters · filed 2016-02-25 | $142.60M derived: sum of 4 quarters · filed 2016-02-25 |
| 2013-09-28 | $40.40M 8-K · filed 2014-11-20 | $81.00M derived: sum of 2 quarters · filed 2016-02-25 | $105.20M derived: sum of 3 quarters · filed 2016-02-25 | |
| 2013-06-29 | $40.60M derived: 10-KT 12 month − 10-Q 9 month · filed 2016-02-25 | $64.80M derived: sum of 2 quarters · filed 2016-02-25 | $104.10M 10-KT · filed 2016-02-25 | |
| 2013-03-30 | $24.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-07 | $63.50M 10-Q · filed 2014-05-07 | ||
| 2012-12-29 | $39.30M 10-Q · filed 2014-02-06 | |||
| 2012-06-30 | $120.20M 10-K · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |